Degradation of GSPT1 causes TP53-independent cell death in leukemia while sparing normal hematopoietic stem cells
Rob S. Sellar(University College London), Benjamin L. Ebert(Dana-Farber Cancer Institute), Veronica Kovalcik(Dana-Farber Cancer Institute), Charles Zou(Dana-Farber Cancer Institute), Ravi Kumar Dutta(Brigham and Women's Hospital), Eric S. Fischer(Dana-Farber Cancer Institute), Elizabeth Henderson(University College London), Katherine A. Donovan(Harvard University), Nada Mageed(Harvard University), Namrata D. Udeshi(Harvard University), Steven A. Carr(Broad Institute), Mikołaj Słabicki(Broad Institute), Amy E. Lin(Brigham and Women's Hospital), Emma C. Fink(Broad Institute), Rajan A. Burt(Broad Institute), Steffen Boettcher(University Hospital of Zurich), Jonas Koeppel(University of Washington), Lu Yang(City of Hope), Chun‐Wei Chen(Chang Gung University), Sheela Pangeni Pokharel(City of Hope), Erik J. Bergstrom(Broad Institute), Adam S. Sperling(Dana-Farber Cancer Institute), Brittany Sandoval(Dana-Farber Cancer Institute), Peter G. Miller(Broad Institute), Marie McConkey(Dana-Farber Cancer Institute), Anthony Chan(City of Hope), Jessica A. Gasser(Broad Institute), Vanessa A. Quevedo Barrios(Brigham and Women's Hospital)
Cited by 64
Related Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
|Proceedings of the National Academy of Sciences|2005|56.5k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
|Science|2006|5.5k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k